These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10575562)

  • 1. Long-term outcome of chronic hepatitis C treated with interferon.
    Hadziyannis SJ; Papatheodoridis GV
    Ital J Gastroenterol Hepatol; 1999; 31(6):459-61. PubMed ID: 10575562
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alfacon-1: new preparation. Basically a me-too interferon alfa.
    Prescrire Int; 2003 Jun; 12(65):95-6. PubMed ID: 12825573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
    Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
    Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving anti-HCV therapy.
    Pol S; Mallet VO
    Discov Med; 2006 Oct; 6(35):187-90. PubMed ID: 17234140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.
    Fernández I; Castellano G; de Salamanca RE; Colina F; Gómez de la Cámara A; Morán MJ; Muñoz R; Solís-Herruzo JA
    Scand J Gastroenterol; 2003 Mar; 38(3):314-9. PubMed ID: 12737448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha treatment for chronic hepatitis C in children.
    Yüce A; Koçak N; Gürakan F; Ozen H
    Turk J Pediatr; 2000; 42(1):34-8. PubMed ID: 10731867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up.
    Spadaro A; Freni MA; Ajello A; Alessi N; Barbaro E; Resta ML; Ferraü O
    Hepatogastroenterology; 1999; 46(30):3229-33. PubMed ID: 10626191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
    Soriano V; Núñez M; Sánchez-Conde M; Barreiro P; García-Samaniego J; Martín-Carbonero L; Romero M; González-Lahoz J
    Antivir Ther; 2005; 10(1):167-70. PubMed ID: 15751774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
    Smith JP
    Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can science meet the challenges of the HCV pandemic: new treatment options for chronic hepatitis C.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Jul; 4(7):24-9. PubMed ID: 11365638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension and hepatitis C virus related cirrhosis.
    Perrone C; Paroli M; Morelli S
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):283-4. PubMed ID: 9646225
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
    Gutkowski K; Gutkowska D; Bilkiewicz T
    Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
    Yu ML; Lin SM; Lee CM; Dai CY; Chang WY; Chen SC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Chuang WL; Liaw YF
    Hepatology; 2006 Nov; 44(5):1086-97. PubMed ID: 17058238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha].
    Mao QG; Liu DL; Zhang MX; Feng XR; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):24-6. PubMed ID: 15670486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients.
    Granot E; Shouval D; Ashur Y
    Mediators Inflamm; 2001 Oct; 10(5):253-8. PubMed ID: 11759109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.